Rick Kelly and Nisha Desai review the proposals in the Pharmaceutical Drug Pricing Reduction Act (PDPRA) with the greatest potential impact.
Just when the Trump administration s drug pricing blueprint has suffered some blows, the Republican and Democratic leaders of the Senate FinanceOriginal Article
